Solid Biosciences
SLDB
SLDB
69 hedge funds and large institutions have $88.5M invested in Solid Biosciences in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1.77% less ownership
Funds ownership: 4.65% → 2.88% (-1.8%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
73% less capital invested
Capital invested by funds: $332M → $88.5M (-$244M)
Holders
69
Holding in Top 10
2
Calls
$3.36M
Puts
$2.71M
Top Buyers
| 1 | +$1.51M | |
| 2 | +$1.47M | |
| 3 | +$1.44M | |
| 4 |
BlackRock
New York
|
+$1.02M |
| 5 |
D.E. Shaw & Co
New York
|
+$832K |
Top Sellers
| 1 | -$69.8M | |
| 2 | -$34.6M | |
| 3 | -$12.7M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.09M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.29M |